市場調查報告書
商品編碼
1518619
2024-2032 年緊急避孕藥市場報告(按類型(複方藥丸、黃體酮藥丸等)、配銷通路(零售店、線上商店等)和地區Emergency Contraceptive Pills Market Report by Type (Combination Pills, Progesterone Pills, and Others), Distribution Channel (Retail Stores, Online Stores, and Others), and Region 2024-2032 |
IMARC Group年,全球緊急避孕藥市場規模達到5.859億美元。大眾對避孕和計劃生育的認知不斷提高、政府和非政府組織(NGO)支持政策的實施以及非荷爾蒙緊急避孕藥的最新發展是推動市場的一些關鍵因素。
緊急避孕藥(ECP)是指用於預防意外懷孕的避孕藥。它們是用合成荷爾蒙製造的,例如左炔諾孕酮,它可以延遲排卵,改變子宮內膜,並防止卵子受精。 ECP 廣泛用於傳統避孕方法失敗期間、無保護性交後、作為缺乏常規避孕藥的備用藥物以及性侵犯犯罪的受害者。它們是安全、經濟有效、容易取得且非常方便的藥物,不會導致長期生育問題,可成功預防意外懷孕,並消除墮胎的需要。 ECP 還可以更好地控制生殖健康,賦予婦女權力,減少焦慮和壓力,並最大限度地減少副作用。
群眾避孕和計劃生育意識的增強是推動市場成長的關鍵因素之一。 ECP 作為一種安全、方便且高度舒適的緊急避孕方式被女性廣泛使用,可防止意外懷孕、保護隱私並最大限度地降低副作用和未來併發症的風險。除此之外,由於無保護性交和性侵犯導致的意外懷孕發生率上升,產品的廣泛使用也是另一個促進成長的因素。此外,政府和非政府組織(NGO)實施支持性政策,以傳播意識、教育大眾並提供方便的緊急避孕藥具,正在對市場成長產生積極影響。此外,最近開發的非荷爾蒙ECP 也為市場成長提供了動力,其中含有醋酸烏利司他,可阻斷體內黃體酮受體,並且與傳統的左炔諾孕酮藥物相比,產生的副作用更少。除此之外,由於全球範圍內對女性健康和福祉的日益關注,產品採用率不斷上升,有利於市場成長。除此之外,對不需要處方且女性在緊急情況下可以輕鬆獲得的非處方(OTC)產品的需求不斷成長,也支撐了市場的成長。此外,製造商透過社群媒體、有影響力的行銷、電視廣告和名人代言積極的促銷和品牌活動也促進了市場的成長。其他因素,包括消費者支出能力的提高、廣泛的研發 (R&D) 活動以及跨電子商務平台的便利產品供應,預計將推動市場成長。
The global emergency contraceptive pills market size reached US$ 585.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 814.3 Million by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032. The increasing awareness among the masses regarding contraception and family planning, the implementation of supportive policies by governments and non-governmental organizations (NGOs), and the recent development of non-hormonal ECPs represent some of the key factors driving the market.
Emergency contraceptive pills (ECPs) refer to birth control medications used for preventing unwanted pregnancies. They are manufactured using synthetic hormones, such as levonorgestrel, which delays ovulation, changes the linings of the uterus, and prevents egg fertilization. ECPs are widely used during the failure of traditional methods of contraception, after unprotected sexual intercourse, as a backup for missing routine birth control pills, and by the victims of sexual assault crimes. They are safe, cost-effective, accessible, and highly convenient medications that do not cause long-term fertility issues, successfully prevent unintended pregnancies, and eliminate the need for abortions. ECPs also provide better control over reproductive health, empower women, reduce anxiety and stress, and minimize side effects.
The increasing awareness among the masses regarding contraception and family planning is one of the key factors propelling the market growth. ECPs are widely used by women as a safe, convenient, and highly comfortable form of emergency contraception, which prevents unwanted pregnancies, maintains privacy, and minimizes the risks of side effects and future complications. Along with this, the widespread product utilization due to rising incidences of unintended pregnancies owing to unprotected intercourse and sexual assault is acting as another growth-inducing factor. Furthermore, the implementation of supportive policies by governments and non-governmental organizations (NGOs) to spread awareness, educate the masses, and provide easy access to emergency contraception is positively influencing the market growth. Additionally, the recent development of non-hormonal ECPs, which contains ulipristal acetate that blocks progesterone receptors in the body and produces fewer side effects compared to traditional levonorgestrel-based pills, is providing an impetus to the market growth. Apart from this, the rising product adoption owing to the increasing focus on women's health and well-being across the globe is favoring the market growth. Besides this, the growing demand for over-the-counter (OTC) products that don't require prescriptions and can be easily accessed by women in case of emergency is supporting the market growth. Moreover, aggressive promotional and branding campaigns by manufacturers through social media, influencer marketing, television (TV) commercials, and celebrity endorsement are contributing to the market growth. Other factors, including rising expenditure capacities of consumers, extensive research and development (R&D) activities, and easy product availability across e-commerce platforms, are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global emergency contraceptive pills market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on type and distribution channel.
Combination Pills
Progesterone Pills
Others
The report has provided a detailed breakup and analysis of the emergency contraceptive pills market based on the type. This includes combination pills, progesterone pills, and others. According to the report, combination pills represented the largest segment.
Retail Stores
Online Stores
Others
A detailed breakup and analysis of the emergency contraceptive pills market based on the distribution channel has also been provided in the report. This includes retail stores, online stores, and others. According to the report, retail stores accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for emergency contraceptive pills. Some of the factors driving the North America emergency contraceptive pills market included the increasing awareness regarding women's health, supportive government policies, and significant technological advancements.
The report has also provided a comprehensive analysis of the competitive landscape in the global emergency contraceptive pills market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Afaxys Pharma LLC, Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Limited, Perrigo Company plc, Piramal Enterprises Ltd., Syzygy Healthcare Solutions LLC, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.